PURPOSE Many patients and physicians remain concerned about the potential detrimental
effects of pregnancy after breast cancer (BC) in terms of reproductive outcomes and …

STUDY QUESTION Is it safe to perform controlled ovarian stimulation (COS) for fertility
preservation before starting anticancer therapies or ART after treatments in young breast …

Background Although recent studies have investigated the ability of Mesenchymal Stromal
Cells (MSCs) to alleviate short-term ovarian damage in animal models of chemotherapy …

A significant number of women receive a cancer diagnosis before their age of natural
menopause. Among these patients, the most frequent neoplasms are breast cancer …

Recent advances in early detection and oncological therapies have ameliorated the survival
rate of young cancer patients. Yet, ovarian impairment induced by chemotherapy and …

Additional age-related issues should be considered when managing breast cancer in young
women. 1 Among them, the potential consequences of anticancer treatments on ovarian …

PURPOSE Fertility and pregnancy-related issues are highly relevant for young (≤ 40 years)
patients with breast cancer. Limited evidence exists on knowledge, practice, and attitudes of …

Women with metastatic breast cancer remains a heterogeneous group of patients with
different prognostic outcomes and therapeutic needs. Young women with de novo metastatic …

Survivorship has become a crucial component in breast cancer care. For women who have
not completed their family planning, conceiving at the end of anticancer treatments should …

Breast cancer diagnosed in premenopausal women tends to be more aggressive and the
benefit of ovarian function suppression (OFS), at least in certain groups of patients, is well …